Lipid droplets in inflammation and cancer

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 4-6, 2010, Pages 243-250

  Bozza, Patricia T ^a   Viola, João P B ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Cancer; Eicosanoids; Inflammation; Lipid bodies; Lipid droplet; Lipid metabolism

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; C 75; CYCLODEPSIPEPTIDE; FAT DROPLET; FATTY ACID SYNTHASE INHIBITOR; ICOSANOID; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLATE SODIUM; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; CELL METABOLISM; CELL ORGANELLE; CELL PROLIFERATION; DISEASE MARKER; DRUG MECHANISM; DRUG TARGETING; ENDOPLASMIC RETICULUM; HUMAN; INFLAMMATION; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; MALIGNANT TRANSFORMATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOPLASMIC VESICLES; EICOSANOIDS; HUMANS; INFLAMMATION; LEUKOCYTES; LIPID METABOLISM; LIPIDS; NEOPLASMS;

EID: 77951978003     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.005     Document Type: Article

References (113)

1. Bozza P.T., Magalhaes K.G., Weller P.F. Leukocyte lipid bodies-biogenesis and functions in inflammation. Biochim. Biophys. Acta 2009, 1791:540-551.
2. Martin S., Parton R.G. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell. Biol. 2006, 7:373-378.
3. Murphy D.J. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 2001, 40:325-438.
4. Robenek M.J., Severs N.J., Schlattmann K., Plenz G., Zimmer K.P., Troyer D., Robenek H. Lipids partition caveolin-1 from ER membranes into lipid droplets: updating the model of lipid droplet biogenesis. FASEB J. 2004, 18:866-868.
5. Brown D.A. Lipid droplets: proteins floating on a pool of fat. Curr. Biol. 2001, 11:R446-R449.
6. Wan H.C., Melo R.C., Jin Z., Dvorak A.M., Weller P.F. Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J. 2007, 21:167-178.
7. Ploegh H.L. A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum. Nature 2007, 448:435-438.
8. Guo Y., Cordes K.R., Farese R.V., Walther T.C. Lipid droplets at a glance. J. Cell. Sci. 2009, 122:749-752.
9. Dvorak A.M., Morgan E., Schleimer R.P., Ryeom S.W., Lichtenstein L.M., Weller P.F. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J. Histochem. Cytochem. 1992, 40:759-769.
10. Dvorak A.M., Morgan E.S., Tzizik D.M., Weller P.F. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int. Arch. Allergy Immunol. 1994, 105:245-250.
11. Dvorak A.M., Weller P.F., Harvey V.S., Morgan E.S., Dvorak H.F. Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int. Arch. Allergy Immunol. 1993, 101:136-142.
12. Bozza P.T., Yu W., Penrose J.F., Morgan E.S., Dvorak A.M., Weller P.F. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J. Exp. Med. 1997, 186:909-920.
13. Arend A., Masso R., Masso M., Selstam G. Electron microscope immunocytochemical localization of cyclooxygenase-1 and -2 in pseudopregnant rat corpus luteum during luteolysis. Prostaglandins Other Lipid Mediat. 2004, 74:1-10.
14. Meadows J.W., Pitzer B., Brockman D.E., Myatt L. Expression and localization of adipophilin and perilipin in human fetal membranes: association with lipid bodies and enzymes involved in prostaglandin synthesis. J. Clin. Endocrinol. Metab. 2005, 90:2344-2350.
15. Thore C.R., Beasley T.C., Busija D.W. In vitro and in vivo localization of prostaglandin H synthase in fetal sheep neurons. Neurosci. Lett. 1998, 242:29-32.
16. Robenek H., Robenek M.J., Troyer D. PAT family proteins pervade lipid droplet cores. J. Lipid Res. 2005, 46:1331-1338.
17. Dvorak A.M. Mast cell secretory granules and lipid bodies contain the necessary machinery important for the in situ synthesis of proteins. Chem. Immunol. Allergy 2005, 85:252-315.
18. Dvorak A.M., Morgan E.S., Weller P.F. RNA is closely associated with human mast cell lipid bodies. Histol. Histopathol. 2003, 18:943-968.
19. Bozza P.T., Payne J.L., Goulet J.L., Weller P.F. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 1996, 183:1515-1525.
20. Weller P.F., Ryeom S.W., Picard S.T., Ackerman S.J., Dvorak A.M. Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J. Cell. Biol. 1991, 113:137-146.
21. 2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2009, 1791:156-165.
22. Bozza P.T., Weller P.F. Arachidonyl trifluoromethyl ketone induces lipid body formation in leukocytes. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64:227-230.
23. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 1995, 57:791-804.
24. Li A.C., Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002, 8:1235-1242.
25. Schmitz G., Grandl M. Lipid homeostasis in macrophages-implications for atherosclerosis. Rev. Physiol. Biochem. Pharmacol. 2008, 160:93-125.
26. Bozza P.T., Yu W., Cassara J., Weller P.F. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J. Leukoc. Biol. 1998, 64:563-569.
27. Bandeira-Melo C., Phoofolo M., Weller P.F. Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J. Biol. Chem. 2001, 276:22779-22787.
28. Maya-Monteiro C.M., Almeida P.E., D'Avila H., Martins A.S., Rezende A.P., Castro-Faria-Neto H., Bozza P.T. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 2008, 283:2203-2210.
29. 4 synthesis within eosinophils. Am. J. Respir. Cell. Mol. Biol. 2005, 33:254-261.
30. Pacheco P., Vieira-de-Abreu A., Gomes R.N., Barbosa-Lima G., Wermelinger L.B., Maya-Monteiro C.M., Silva A.R., Bozza M.T., Castro-Faria-Neto H.C., Bandeira-Melo C., Bozza P.T. Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 2007, 179:8500-8508.
31. de Assis E.F., Silva A.R., Caiado L.F., Marathe G.K., Zimmerman G.A., Prescott S.M., McIntyre T.M., Bozza P.T., de Castro-Faria-Neto H.C. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. J. Immunol. 2003, 171:2090-2098.
32. 4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J. Immunol. 2006, 176:1326-1330.
33. Bandeira-Melo C., Sugiyama K., Woods L.J., Phoofolo M., Center D.M., Cruikshank W.W., Weller P.F. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J. Immunol. 2002, 168:4756-4763.
34. Bartemes K.R., McKinney S., Gleich G.J., Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J. Immunol. 1999, 162:2982-2989.
35. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 1979, 76:333-337.
36. de Villiers W.J., Smart E.J. Macrophage scavenger receptors and foam cell formation. J. Leukoc. Biol. 1999, 66:740-746.
37. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell. Metab. 2006, 4:211-221.
38. Hodgkinson C.P., Laxton R.C., Patel K., Ye S. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2275-2281.
39. Zhao Z., de Beer M.C., Cai L., Asmis R., de Beer F.C., de Villiers W.J., van der Westhuyzen D.R. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler. Thromb. Vasc. Biol. 2005, 25:168-173.
40. Buechler C., Ritter M., Duong C.Q., Orso E., Kapinsky M., Schmitz G. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim. Biophys. Acta 2001, 1532:97-104.
41. Kapinsky M., Torzewski M., Buchler C., Duong C.Q., Rothe G., Schmitz G. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1004-1010.
42. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52:223-261.
43. Silva A.R., de Assis E.F., Caiado L.F., Marathe G.K., Bozza M.T., McIntyre T.M., Zimmerman G.A., Prescott S.M., Bozza P.T., Castro-Faria-Neto H.C. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J. Immunol. 2002, 168:4112-4120.
44. Chen J.S., Greenberg A.S., Tseng Y.Z., Wang S.M. Possible involvement of protein kinase C in the induction of adipose differentiation-related protein by Sterol ester in RAW 264.7 macrophages. J. Cell. Biochem. 2001, 83:187-199.
45. Leonarduzzi G., Chiarpotto E., Biasi F., Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 2005, 49:1044-1049.
46. Boullier A., Friedman P., Harkewicz R., Hartvigsen K., Green S.R., Almazan F., Dennis E.A., Steinberg D., Witztum J.L., Quehenberger O. Phosphocholine as a pattern recognition ligand for CD36. J. Lipid Res. 2005, 46:969-976.
47. Silva A.R., Pacheco P., Vieira-de-Abreu A., Maya-Monteiro C.M., D'Alegria B., Magalhaes K.G., de Assis E.F., Bandeira-Melo C., Castro-Faria-Neto H.C., Bozza P.T. Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim. Biophys. Acta 2009, 1791:1066-1075.
48. Dvorak A.M. Biochemical contents of granules and lipid bodies-two distinctive organelles found in basophils and mast cells. Basophil and Mast Cell Degranulation and Recovery 1991, Plenum Press, New York.
49. Franke W.W., Hergt M., Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell 1987, 49:131-141.
50. Mermelstein C.S., Guma F.C., Mello T.G., Fortuna V.A., Guaragna R.M., Costa M.L., Borojevic R. Induction of the lipocyte phenotype in murine hepatic stellate cells: reorganisation of the actin cytoskeleton. Cell. Tissue Res. 2001, 306:75-83.
51. Pol A., Martin S., Fernandez M.A., Ferguson C., Carozzi A., Luetterforst R., Enrich C., Parton R.G. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell 2004, 15:99-110.
52. Bostrom P., Rutberg M., Ericsson J., Holmdahl P., Andersson L., Frohman M.A., Boren J., Olofsson S.O. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1945-1951.
53. Xu W., Yu L., Zhou W., Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem. Biophys. Res. Commun. 2006, 351:376-382.
54. Maya-Monteiro C.M., Bozza P.T. Leptin and mTOR: partners in metabolism and inflammation. Cell. Cycle 2008, 7:1713-1717.
55. Larigauderie G., Furman C., Jaye M., Lasselin C., Copin C., Fruchart J.C., Castro G., Rouis M. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:504-510.
56. Wang S.M., Hwang R.D., Greenberg A.S., Yeo H.L. Temporal and spatial assembly of lipid droplet-associated proteins in 3T3-L1 preadipocytes. Histochem. Cell. Biol. 2003, 120:285-292.
57. Gross D.N., Miyoshi H., Hosaka T., Zhang H.H., Pino E.C., Souza S., Obin M., Greenberg A.S., Pilch P.F. Dynamics of lipid droplet-associated proteins during hormonally stimulated lipolysis in engineered adipocytes: stabilization and lipid droplet binding of adipocyte differentiation-related protein/adipophilin. Mol. Endocrinol. 2006, 20:459-466.
58. Chung S., Brown J.M., Sandberg M.B., McIntosh M. Trans-10,cis-12 CLA increases adipocyte lipolysis and alters lipid droplet-associated proteins: role of mTOR and ERK signaling. J. Lipid Res. 2005, 46:885-895.
59. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
60. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 1993, 90:2160-2164.
61. Gearing K.L., Gottlicher M., Teboul M., Widmark E., Gustafsson J.A. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 1993, 90:1440-1444.
62. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229-240.
63. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93:241-252.
64. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
65. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 2001, 7:48-52.
66. Almeida P.E., Silva A.R., Maya-Monteiro C.M., Torocsik D., Avila H.D., Dezso B., Magalhaes K.G., Castro-Faria-Neto H.C., Nagy L., Bozza P.T. Mycobacterium bovis Bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor {gamma} expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 2009, 183:1337-1345.
67. D'Avila H., Roque N.R., Cardoso R.M., Castro-Faria-Neto H.C., Melo R.C., Bozza P.T. Neutrophils recruited to the site of mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell. Microbiol. 2008, 10:2589-2604.
68. Samsa M.M., Mondotte J.A., Iglesias N.G., Assuncao-Miranda I., Barbosa-Lima G., Da Poian A.T., Bozza P.T., Gamarnik A.V. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS. Pathog. 2009, 5:e1000632.
69. Accioly M.T., Pacheco P., Maya-Monteiro C.M., Carrossini N., Robbs B.K., Oliveira S.S., Kaufmann C., Morgado-Diaz J.A., Bozza P.T., Viola J.P. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res. 2008, 68:1732-1740.
70. Swinnen J.V., Brusselmans K., Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:358-365.
71. Kuhajda F.P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006, 66:5977-5980.
72. Than N.G., Sumegi B., Bellyei S., Berki T., Szekeres G., Janaky T., Szigeti A., Bohn H., Than G.N. Lipid droplet and milk lipid globule membrane associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical carcinoma cells. Eur. J. Biochem. 2003, 270:1176-1188.
73. Opstad K.S., Bell B.A., Griffiths J.R., Howe F.A. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRSand histological analysis. NMR Biomed. 2008, 21:677-685.
74. Hirano T., Morii H., Nakazawa K., Murakami D., Yamashita A., Asahi J., Orimo H., Tamae K., Tokura Y. Enhancement of adipogenesis induction by conditioned media obtained from cancer cells. Cancer Lett. 2008, 268:286-294.
75. Yaqoob P. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol. 2003, 24:639-645.
76. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat. Rev. Mol. Cell. Biol. 2008, 9:162-176.
77. Dvorak A.M., Dvorak H.F., Peters S.P., Shulman E.S., MacGlashan D.W., Pyne K., Harvey V.S., Galli S.J., Lichtenstein L.M. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 1983, 131:2965-2976.
78. Weller P.F., Ackerman S.J., Nicholson-Weller A., Dvorak A.M. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 1989, 135:947-959.
79. Weller P.F., Monahan-Earley R.A., Dvorak H.F., Dvorak A.M. Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. Am. J. Pathol. 1991, 138:141-148.
80. Plotkowski M.C., Brandao B.A., de Assis M.C., Feliciano L.F., Raymond B., Freitas C., Saliba A.M., Zahm J.M., Touqui L., Bozza P.T. Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb. Pathog. 2008, 45:30-37.
81. Six D.A., Dennis E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta 2000, 1488:1-19.
82. Ghosh M., Tucker D.E., Burchett S.A., Leslie C.C. Properties of the Group IV phospholipase A2 family. Prog. Lipid Res. 2006, 45:487-510.
83. 2 at cytoplasmic arachidonate-rich lipid bodies. Am. J. Pathol. 1998, 152:759-769.
84. Wooten R.E., Willingham M.C., Daniel L.W., Leslie C.C., Rogers L.C., Sergeant S., O'Flaherty J.T. Novel translocation responses of cytosolic phospholipase A(2)alpha fluorescent proteins. Biochim. Biophys. Acta 2008, 1783:1544-1550.
85. Pacheco P., Bozza F.A., Gomes R.N., Bozza M., Weller P.F., Castro-Faria-Neto H.C., Bozza P.T. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J. Immunol. 2002, 169:6498-6506.
86. D'Avila H., Melo R.C., Parreira G.G., Werneck-Barroso E., Castro-Faria-Neto H.C., Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 2006, 176:3087-3097.
87. Bozza P.T., Payne J.L., Morham S.G., Langenbach R., Smithies O., Weller P.F. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc. Natl. Acad. Sci. USA 1996, 93:11091-11096.
88. Weller P.F., Bozza P.T., Yu W., Dvorak A.M. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 1999, 118:450-452.
89. Melo R.C., D'Avila H., Fabrino D.L., Almeida P.E., Bozza P.T. Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell 2003, 35:59-67.
90. C. Bandeira Melo, P.F. Weller, P.T. Bozza, Eicosacell-an immunofluorescent-based assay to localize newly synthesized eicosanoid lipid mediators at intracellular sites methods, Methods Mol. Biol., in press.
91. Bandeira-Melo C., Bozza P.T., Weller P.F. The cellular biology of eosinophil eicosanoid formation and function. J. Allergy Clin. Immunol. 2002, 109:393-400.
92. Seachord C.L., VandeVoort C.A., Duffy D.M. Adipose differentiation-related protein: a gonadotropin- and prostaglandin-regulated protein in primate periovulatory follicles. Biol. Reprod. 2005, 72:1305-1314.
93. Meadows J.W., Eis A.L., Brockman D.E., Myatt L. Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor. J. Clin. Endocrinol. Metab. 2003, 88:433-439.
94. Scarfo L.M., Weller P.F., Farber H.W. Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H294-H301.
95. Yu W., Cassara J., Weller P.F. Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood 2000, 95:1078-1085.
96. Pol A., Luetterforst R., Lindsay M., Heino S., Ikonen E., Parton R.G. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell. Biol. 2001, 152:1057-1070.
97. Fujimoto T., Kogo H., Ishiguro K., Tauchi K., Nomura R. Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J. Cell. Biol. 2001, 152:1079-1085.
98. Chen J.S., Greenberg A.S., Wang S.M. Oleic acid-induced PKC isozyme translocation in RAW 264.7 macrophages. J. Cell. Biochem. 2002, 86:784-791.
99. Cohen A.W., Razani B., Schubert W., Williams T.M., Wang X.B., Iyengar P., Brasaemle D.L., Scherer P.E., Lisanti M.P. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004, 53:1261-1270.
100. Sato S., Fukasawa M., Yamakawa Y., Natsume T., Suzuki T., Shoji I., Aizaki H., Miyamura T., Nishijima M. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem. 2006, 139:921-930.
101. Fernandez M.A., Albor C., Ingelmo-Torres M., Nixon S.J., Ferguson C., Kurzchalia T., Tebar F., Enrich C., Parton R.G., Pol A. Caveolin-1 is essential for liver regeneration. Science 2006, 313:1628-1632.
102. Kurat C.F., Wolinski H., Petschnigg J., Kaluarachchi S., Andrews B., Natter K., Kohlwein S.D. Cdk1/Cdc28-dependent activation of the major triacylglycerol lipase Tgl4 in yeast links lipolysis to cell-cycle progression. Mol. Cell 2009, 33:53-63.
103. Yao M., Tabuchi H., Nagashima Y., Baba M., Nakaigawa N., Ishiguro H., Hamada K., Inayama Y., Kishida T., Hattori K., Yamada-Okabe H., Kubota Y. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J. Pathol. 2005, 205:377-387.
104. Yao M., Huang Y., Shioi K., Hattori K., Murakami T., Nakaigawa N., Kishida T., Nagashima Y., Kubota Y. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin. Cancer Res. 2007, 13:152-160.
105. Bozza P.T., Pacheco P., Yu W., Weller P.F. NS-398: cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67:237-244.
106. Paul A., Chang B.H., Li L., Yechoor V.K., Chan L. Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis. Circ. Res. 2008, 102:1492-1501.
107. Namatame I., Tomoda H., Ishibashi S., Omura S. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. Proc. Natl. Acad. Sci. USA 2004, 101:737-742.
108. Bozza P.T., D'Avila H., Almeida P.E., Magalhaes K.G., Molinaro R., Almeida C.J., Maya-Monteiro C.M. Lipid droplets in host-pathogen interactions. Clin. Lipidol. 2009, 4:791-807.
109. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell. Biol. 2007, 9:1089-1097.
110. Boulant S., Targett-Adams P., McLauchlan J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 2007, 88:2204-2213.
111. Sheng H., Shao J., Morrow J.D., Beauchamp R.D., DuBois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998, 58:362-366.
112. Sheng H., Shao J., Washington M.K., DuBois R.N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 2001, 276:18075-18081.
113. Tsujii M., DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83:493-501.